Winship Melanoma and Cutaneous Oncology Symposium

Lectures and Training

The Winship Melanoma and Cutaneous Oncology Symposium will be held on Saturday, March 2, 2024 at the Emory Conference Center Hotel.

The Winship Cancer Institute Melanoma and Cutaneous Oncology Symposium serve as a valuable forum for the presentation and discussion of newly available data. Participants will be provided with an update on practice-changing data in a practical and interactive format, fostering discussion and impacting clinical outcomes for patients with melanoma and non-melanoma skin cancer.

TARGET AUDIENCE
This activity is specifically designed to meet the needs of dermatologists, medical, surgical, and radiation oncologists, hematologists, residents, fellows, advanced practice providers, nurses, and pharmacists.

CONTINUING EDUCATION CREDIT
The Emory University School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Emory University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

LEARNING OBJECTIVES
After successful completion of this educational activity, participants should be able to:

• Identify recent advances and current status of neoadjuvant and adjuvant treatment of melanoma
• Discuss recent advances in surgical management of the nodal basin in melanoma
• Describe pathologic evaluation of pigmented lesions and regional lymph nodes, including evaluation of nodes after neoadjuvant treatment
• Discuss new insights into melanoma and detection and prevention
• Discuss current approaches to management of non-melanoma skin cancers
• Describe approaches to treatment of anti-PD-1 refractory melanoma
• Describe recent approaches to multidisciplinary management of Merkel cell carcinoma

COURSE DIRECTORS

• David H. Lawson, MD, Winship Cancer Institute of Emory University
• Michael Lowe, MD, MA, Winship Cancer Institute of Emory University

INVITED SPEAKERS

• Christopher Barker, MD, Memorial Sloan Kettering Cancer Center
• Suephy Chen, MD, MS, Duke University School of Medicine
• Mark B. Faries, MD, Cedars Sinai Medical Center
• Sapna Patel, BA, MD, UT MD Anderson Cancer Center
• Michael T. Tetzlaff, MD, PhD, University of California, San Francisco

INVITED PANELISTS

• Janice Mehnert, MD, Perlmutter Cancer Center of NYU Langone Health
• Rajni Sinha, MD, MRCP, Piedmont Cancer Institute
• Samantha Shams, MD, Piedmont Cancer Institute
• Humza Ilyas, MD, Olansky Dermatology & Aesthetics
• Carl Washington, MD, Dermatology Associates of Georgia
• Nicole Kounalakis, MD, Northside Melanoma and Sarcoma Specialists of Georgia
• Jacob Choi, MD, Winship Cancer Institute of Emory University
• Julie Barber, MD, Finan Templeton Dermatopathology Associates
• Jamie Weisman, MD, Medical Dermatology Specialists, Inc.
• Suephy Chen, MD, MS, Duke University School of Medicine 

• Melanoma 2024.pdf -